Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Mekinist |
| Active Ingredient: | Trametinib dimethyl sulfoxide 0.5635mg equivalent to trametinib 0.5mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturers: | Novartis Pharma Stein AG, Stein, Switzerland GlaxoSmithKline Manufacturing SpA, Parma, Italy |
| Product: | Mekinist |
| Active Ingredient: | Trametinib dimethyl sulfoxide 2.254mg equivalent to trametinib 2mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturers: | Novartis Pharma Stein AG, Stein, Switzerland GlaxoSmithKline Manufacturing Spa, Parma, Italy |
Dated this 22nd day of August 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).